Results 111 to 120 of about 79,389 (158)

miR-3678-3p Promotes Esophageal Squamous Cell Carcinoma Progression by Regulating Phosphatase and Tensin Homolog. [PDF]

Turk J Gastroenterol
Zhang J, Cheng C, Li T.
europepmc   +1 more source

Serum Untargeted Metabolomics Profiling of Esophageal Squamous Cell Carcinoma in High-Incidence Areas of China. [PDF]

Int J Gen Med
Li Y, Zhou L, Huang R, Wu Z, Guan J, Qiao X, Kong Y, Gan Y, Zhang Y, Li J.   +9 more
europepmc   +1 more source

Pyrimethamine Restores KEAP1-Mediated Degradation of Select NRF2 Mutants in Esophageal Squamous Cell Carcinoma. [PDF]

Cancers (Basel)
Xiong Z, Paiboonrungruang C, Wang H, Subramaniyan B, Bui-Linh C, Li Y, Li H, Wang MC, Spitz F, Chen X.   +9 more
europepmc   +1 more source

Immunotherapy-based adjuvant treatment after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma according to pathological response. [PDF]

Front Immunol
Wang C, Geng X, Cheng X, Ren R, Jin L, Sheng Z, Li S, Zang M, Zhang Y.   +8 more
europepmc   +1 more source

Silencing of small nuclear ribonucleoprotein polypeptide B inhibits the progression of esophageal squamous cell carcinoma. [PDF]

Oncol Lett
Guo H, Zuo J, Hu G, Tang Y, Lu L, Luo Z, Chen X, Wang X, Wang X.   +8 more
europepmc   +1 more source

Identification and validation of prognostic genes related to mitochondrial dynamics and mitochondrial autophagy in esophageal squamous cell carcinoma. [PDF]

J Thorac Dis
Lin H, Zhuang FN, Chen WJ, Wei WW, Gao PQ, Wang PY, Wang F, Shi S.   +7 more
europepmc   +1 more source

Preoperative Circulating Tumor DNA Detection and Risk Stratification in Esophageal Squamous Cell Carcinoma.

JAMA Surg
Hong TH, Jeong JG, Park SY, Park BJ, Kyung D, Kim HP, Zhu J, Yang YH, Kim HE, Lee CY, Lee JG, Jeon YJ, Lee J, Cho JH, Choi YS, Shim YM, Lee SH, Kim DJ, Kim HK.   +18 more
europepmc   +1 more source

Response to nivolumab as an immune checkpoint inhibitor rechallenge for esophageal squamous cell carcinoma with <i>PD-L1</i> amplification: a case report. [PDF]

Ther Adv Med Oncol
Kodama H, Masuishi T, Ishizuka Y, Sakakida T, Honda K, Narita Y, Taniguchi H, Kadowaki S, Ando M, Hosoda W, Muro K.   +10 more
europepmc   +1 more source

A combined immune-nutritional score as a prognostic indicator in neoadjuvant-treated esophageal squamous cell carcinoma. [PDF]

Front Immunol
Xie Q, Zhan J, Ye X, Huang C, Chen C, Zheng B, Xu G, Yang Z, Zhu Y.   +8 more
europepmc   +1 more source

LEF1/NFE2L3/TACC1 axis activates the AKT-mTOR pathway to promote the progression of esophageal squamous cell carcinoma. [PDF]

J Thorac Dis
Li H, Xu S, Li N, Xu T, Li T, Chen H, Lu Q.   +6 more
europepmc   +1 more source